P. Cerqueti - Concepedia

Author

P. Cerqueti

University of Genoa

Also Known As

P Cerqueti, P. Cerqueti, P. M. Cerqueti, P.M Cerqueti, P.M. Cerqueti, Piera Cerqueti, Piera M. Cerqueti

Publications

513

Citations

H-Index

Concepts

All Affiliations

University of Genoa

About

P. Cerqueti is an author at University of Genoa specializing in medicine, ophthalmology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	180
2	Allergy	2	2	66
3	Allergy Medicine	2	2	66
4	Immunology	2	2	114
5	Pathology	1	1	95

P. Cerqueti

Publications

425

Citations

H-Index

Page 1

	Year	Citations
Fluctuations of Intraocular Pressure during the Day in Open-Angle Glaucoma, Normal-Tension Glaucoma and Normal Subjects Sergio Claudio Saccà, Maurizio Rolando, Antonio Marletta, Ophthalmologica	1998	184
Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossmann syndrome E Bloch-Michel, E Dussaix, P. Cerqueti, International Ophthalmology Cytomegalovirus InfectionViral PersistencePathogenesisImmunologyPathology	1987	95
New Approaches to the Detection of Locally Produced Antiviral Antibodies in the Aqueous of Patients with Endogenous Uveitis Élisabeth Dussaix, P. Cerqueti, Françoise Pontet, Ophthalmologica	1987	49
Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis P Vérin, D L Easty, Antonio Secchi, American Journal of Ophthalmology Ocular DiseaseAllergyOphthalmologyAllergy MedicineEye Health	2001	38
Lodoxamide Treatment of Allergic Conjunctivitis P. Cerqueti, Valdo Ricca, Maria Angela Tosca, International Archives of Allergy and Immunology Drug HypersensitivityLodoxamide TreatmentInflammatory CellsAllergyOphthalmology	1994	28
Loratadine reduces the expression of ICAM‐1 Giorgio Ciprandi, A. Catrullo, P. Cerqueti, Allergy Molecular PharmacologyMolecular PhysiologyMedicineImmunologyMechanism Of Action	1998	19
Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study Gemma Caterina Maria Rossi, Giulio Maria Pasinetti, Maurizio Bracchino, Expert Opinion on Pharmacotherapy	2009	12

Page 1